The Compression Therapy Market Size was valued at USD 3.1 billion in 2022 and is projected to grow from USD 3.7 Billion in 2023 to USD 5.2 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.4% during the forecast period (2023 - 2032). Increase in the number of sports-related injuries, the number of people with chronic venous insufficiency (CVI), and the constant migration of treatment facilities from hospitals and clinics to homes are all major market drivers that are predicted to contribute to the market's revenue growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The market's revenue growth is expected to be influenced by many significant market factors, including the rise in sports-related injuries, the prevalence of chronic venous insufficiency (CVI) among individuals, and the ongoing shift of treatment facilities from traditional hospital and clinic settings to home-based care. The increasing need for sport-specific sleeves, gloves, stockings, and other gear is a significant driver behind the growth of this market. The aforementioned apparel exhibits ease of application in the specific region, so enabling athletes who encounter Delayed Onset Muscle Soreness (DOMS), Chronic Venous Insufficiency (CVI), or muscle fatigue to continue their physical endeavors without interruption.
Traffic accidents are widely recognized as a prominent contributor to both death and disability on a global scale, with sports-related injuries ranking closely behind in terms of prevalence and impact. Incidents involving accidents often result in skeletal system injuries of varying degrees of severity. Compression therapy devices are commonly employed in such circumstances to facilitate the process of healing and expedite the recovery of patients. Globally, there is a noticeable increase in the number of persons who are actively participating in sports and engaging in physical activities. This trend can be attributed to the heightened awareness around health and fitness. The prevalence of sports-related injuries and injuries arising from other types of physical exercise has correspondingly escalated due to this phenomenon.
Â
Moreover, there is a rapid increase in the global incidence of lymphatic and venous disorders. Several risk factors, such as varicose veins, pregnancy, obesity, previous deep vein thrombosis, and immobility, are known to contribute to the development of these conditions. Furthermore, several medical disorders such as breast cancer, chronic venous insufficiency, and surgical procedures might lead to lymphatic complications. The increasing awareness of advanced therapeutic interventions, such as compression garments and other devices, along with the growing prevalence of these ailments, is expected to drive the development of the market.Â
May 2023:Using rapid cell compression and re-expansion to actively transport a target payload into the cell, CellFE Inc., a pioneering microfluidics company committed to revolutionizing the development and manufacture of advanced cell therapies, has announced the commercial availability of its Infinity Mtx cellular engineering platform. High yields of altered cells, faster vein-to-vein times, cheaper production costs, and more efficient absorption of different payloads are all benefits of CellFE's microfluidic cellular engineering platform.
One of the leading causes of mortality and disability around the world is traffic accidents, followed by sports-related injuries. Accident situations are frequently accompanied by moderate or severe skeletal system injuries. Compression treatment devices are frequently utilised in these situations to help the healing process and hasten patient recovery. Over the world, more individuals are actively engaging in sports and physical activities (as a result of the growing awareness about health and fitness). The frequency of sports injuries and injuries resulting from other forms of physical activity has consequently increased as a result of this trend. 8.6 million sports injuries are reported each year in the US alone. Thus, this factor is driving the market CAGR for compression therapy.Figure 1: Estimates injuries associated with sports & recreational activities
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Furthermore, globally, the prevalence of lymphatic and venous illnesses is rising quickly. Varicose veins, pregnancy, obesity, past deep vein thrombosis, and immobility are among the risk factors that contribute to the development of these illnesses. Moreover, conditions including breast cancer, chronic venous insufficiency, and operations cause lymphatic problems. Thus, rising knowledge of cutting-edge therapies including compression garments and other gadgets as well as rising prevalence of these disorders will probably fuel market expansion. For instance, venous leg ulceration, which affects 1.5% of the general population and up to 5% of the elderly, is the most prevalent medical problem in the world, according to an article in vascular medicine.
However, throughout the forecast period, a number of new advancements in compression therapy are anticipated to drive this therapy market growth. Traditional treatment alternatives like single-component compression systems are multi-component, bi-layer compression therapy systems. The multi-component system consists of an elastic bandage, an elastic cohesive bandage, wool padding, and a crepe layer. With the addition of each layer of compression, the interface pressure under the bandages rises, giving multiple systems an advantage over single component systems in terms of efficiency. A growing number of industry titans are also concentrating on the creation of new compression therapy devices with increased efficacy. For instance, in January 2020, the FDA granted AIROS Medical Inc. permission to market its revised AIROS 8 Sequential Compression Treatment Device and garment system. AIROS Medical Inc. is a manufacturer of medical technology that specializes in these therapeutic devices. Thus, it is anticipated that this aspect will accelerate compression therapy market revenue globally.
The market of Compression Therapy segmentation, based on technique, includes Static and Dynamic. The static segment held the majority share in 2022 in the Compression Therapy Market data. Static therapy devices are becoming more popular because to their low cost, wide availability, and simplicity of use, which is propelling the expansion of this market. Furthermore, patients can use these devices while working, which is anticipated to raise demand for athletes and fitness instructors.
Figure 2: Â Compression Therapy Market, by Technique, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The  Compression Therapy Market segmentation, based on product, includes Compression Garments, Compression Pump and Compression Braces. The compression garments segment dominated the market growth for compression therapy in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The rising need for athletic-specific sleeves, gloves, stockings, and other apparel is one of the major factors boosting this market's expansion. These garments are simple to put on in the affected area, allowing athletes who experience DOMS, CVI, or muscular weariness to carry on with their activity uninterrupted.
The Market data of Compression Therapy, based on application, includes Varicose Vein, Deep Vein Thrombosis, Lymphedema and Leg Ulcer. The lymphedema segment dominated the compression therapy market revenue for compression therapy in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Lymphedema is characterized by tissue swelling brought on by a buildup of fluid, which is typically eliminated by the body's lymphatic system. It causes infections to return and causes limb edema. One of the best ways to treat the condition is intermittent pneumatic compression. Compression clothing gradually increases pressure, allowing lymphatic fluid to circulate and allow for adequate drainage.
March 2023:It is with great pleasure that we announce a strategic partnership between Aspen Medical Products (Aspen), the market leader in mobility and pain management solutions, and NICE Recovery Systems (NICE), the market leader in the recovery space for sports injuries, effective in March 2023. By working together, NICE's cutting-edge cold compression technology and Aspen's tried-and-true bracing solutions can help patients cope with pain after surgery or an injury.Â
By region, the study provides the market insights for compression therapy into North America, Europe, Asia-Pacific and Rest of the World. North America compression therapy market accounted for USD 1.3 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The market in this area is expanding quickly due to recent developments in the healthcare industry. Additionally, it is anticipated that over the course of the forecast period, an increase in the quantity of sporting events, an increase in the frequency of sports injuries, and the presence of numerous manufacturers of compression therapy products in the area will significantly boost market revenue.
Further, the major countries studied in the market report for compression therapy are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: Â COMPRESSION THERAPY MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Asia Pacific compression therapy market accounts for the second-largest market share due to the substantial presence of important industries in the region's nations. Moreover, rising disposable incomes, population growth, expanding healthcare spending, and rising physician and patient awareness are just a few of the market-driving variables. Moreover, China market of compression therapy held the largest market share, and the India market of compression therapy was the fastest growing market in the region.
Europe compression therapy Market is expected to grow at the fastest CAGR from 2022 to 2030. This is explained by the rise in geriatric patients and athletes with venous and muscular issues. Some factors that are projected to accelerate the market growth rate in Europe include rapid urbanization and advancements in the healthcare industry. Further, the UK market of compression therapy held the largest market share, and the Germany market of compression therapy was the fastest growing market in the region.
Compression Therapy Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of compression therapy grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the compression therapy industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the global compression therapy industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, compression therapy industry has provided medicine with some of the most significant benefits. The compression therapy market major player such as 3M, Medtronic PLC, Bio Compression Systems Inc., BSN Medical, Medi GmbH & Co. Kg, Paul Hartmann AG, Smith & Nephew PLC., Cardinal Health Inc., Sigvaris, Sanyleg S.R.L, Tactile Medical and Convatec.
One of the medical device industries' companies with the quickest growth is Tactile Medical. Tactile Medical, a pioneer in lymphedema and venous ulcer therapies, creates cutting-edge home therapy devices to enhance patients with chronic swelling's health and quality of life. In September 2021, Tactile Medical Systems reported that it had acquired the assets of International Biophysics' AffloVest Respiratory Treatment Company through cash transactions and borrowings from a credit facility. International Biophysics created the AffloVest to treat patients with chronic respiratory illnesses such cystic fibrosis, neuromuscular difficulties, and breathing issues related to chronic obstructive pulmonary disease (COPD) by opening airways using high-frequency chest wall oscillations.
Medical equipment and supplies are produced by medi GmbH & Company KG. The company provides limb amputees with prosthetic care, orthoses, antiembolism, stockings, compression apparel, and other medical supplies for various therapies. Germany is where Medi operates. Germany serves as the location of medi's corporate offices. In June 2020, a significant addition to the company's flat-knit compression range, Mediven Cosy 450 was introduced by Medi GmbH. The item offers anatomical foot shape for an excellent fit and high B64down stretch elasticity.
Key Companies in the compression therapy market includes
Compression Therapy Industry Developments
June 2022:Â The latest version of the renowned Normatec line, Normatec 3 by Hyperice, which uses dynamic air compression to promote daily health and support quicker recovery, better training, and optimal performance, was featured by Hyperice, a global high-performance wellness brand. Scientific research has demonstrated that taking Normatec can improve range of motion while lowering pain sensitivity and muscle soreness after exercise.
February 2022:Â Essity Medical Solutions paid USD 40 million and an additional USD 10 million earnout payment to purchase Legacy Converting, Inc., a U.S.-based professional wiping and cleaning business, through cash-only and debt-free transactions. Through the addition of the latter company's hygiene products to its portfolio and the development of sustainable hygiene products and services, the acquisition is anticipated to increase the former company's product diversity. The Everwipe brand of roll and folded wipes, which will be incorporated into the hygiene products of the Tork brand, is a product of Legacy Converting, Inc.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 3.1 billion |
| Market Size 2023 | USD 3.7 billion |
| Market Size 2032 | USD 5.2 billion |
| Compound Annual Growth Rate (CAGR) | Â 5.4% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018 - 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Technique, Product, Application and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | 3M, Medtronic PLC, Bio Compression Systems Inc., BSN Medical, Medi GmbH & Co. Kg, Paul Hartmann AG, Smith & Nephew PLC., Cardinal Health Inc. |
| Key Market Opportunities | Rising research and development investments |
| Key Market Dynamics | Increasing incidence of sports injuries and accidents, technological advancements Rising patient awareness regarding the benefits of compression therapy |
Compression Therapy Market Highlights:
Frequently Asked Questions (FAQ) :
The Compression Therapy Market size was valued at USD 5.2 billion in 2032.
The Compression Therapy Market is projected to grow at a CAGR of 5.4% during the forecast period, 2022-2032.
North America had the largest share in the global market for compression therapy.
The key players in the market for compression therapy are 3M, Medtronic PLC, Bio Compression Systems Inc., BSN Medical, Medi GmbH & Co. Kg, Paul Hartmann AG, Smith & Nephew PLC., Cardinal Health Inc.
The static dominated the compression therapy market in 2022.
The compression garments had the largest share in the Compression Therapy Market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
